Search

everythinglearnresearchcommunity

for

Search:↓

Smaller finasteride particles increase effectiveness in treating hair loss.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Tripeptides help heal wounds and regenerate skin by speeding up tissue repair and reducing inflammation.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

HPV 60 may cause cysts and warts on the face, not just hands and feet.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

Most skin cysts were common types found in unusual body parts, and examining tissue samples is important for accurate diagnosis.

The editor suggests removing "race" and "ethnicity" from dermatology and creating tools to objectively assess skin color and hair texture.

Severe acne in a young girl may indicate underlying hormonal issues.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

Women with hair loss had lower IGF-1 levels.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Homeopathic treatment improved symptoms and thyroid levels in a woman with subclinical hypothyroidism.

Trichoscopy is a valuable tool for accurately diagnosing scalp conditions without invasive procedures.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Adipose-derived stem cells can be transformed into hair-forming cells using specific extracellular vesicles, offering potential for hair regeneration therapies.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.